Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M L, Kelsten"'
Autor:
W G, McKenna, M C, Weiss, B, Endlich, C C, Ling, V J, Bakanauskas, M L, Kelsten, R J, Muschel
Publikováno v:
Cancer research. 50(1)
Resistance of tumors to irradiation or chemotherapeutic agents is thought to be one of the reasons why patients who present with early malignancies may not be cured. Much is now known about the molecular mechanisms that underlie drug resistance, but
Publikováno v:
Obstetrics and gynecology. 75(1)
Ovarian carcinoma disseminates primarily through the shedding of cells into the peritoneal cavity and subsequent implantation onto peritoneal surfaces. Accurate evaluation of the extent of disease is important both at initial surgical evaluation for
Publikováno v:
Clinical Chemistry. 32:1318-1322
A monoclonal immunoenzymometric assay for alpha-fetoprotein was evaluated for detection and monitoring of hepatocellular carcinoma (HCC). We studied 1343 serum specimens from 759 patients with various neoplastic and non-neoplastic diseases. The inter
Publikováno v:
Clinical Chemistry. 34:76-81
A monoclonal immunoenzymometric assay for alpha-fetoprotein (M-AFP) was evaluated with respect to its utility in monitoring hepatocellular carcinoma (HCC) patients. Earlier (Clin Chem 1986;32:1318-22), we found this immunoassay to demonstrate abiliti
Publikováno v:
The American journal of pathology. 135(4)
The low (NF-L) and middle (NF-M) molecular weight (Mr) neurofilament (NF) subunits are expressed before the high (NF-H) Mr NF subunit in embryonic neurons. Thereafter, NF-M attains its mature state of phosphorylation more rapidly than does NF-H. Howe
Autor:
Miyazono, Masayuki, Nowell, Peter C., Finan, Janet L., Lee, Virginia M.-Y., Trojanowski, John Q.
Publikováno v:
Journal of Comparative Neurology; 1996, Vol. 376 Issue 4, p603-613, 11p
Publikováno v:
Journal of Comparative Neurology; 1993, Vol. 334 Issue 3, p356-369, 14p
Autor:
Carleton T. Garrett, Stewart Sell
In Cellular Cancer Markers leading pathologists and physicians review today's most promising cellular cancer markers, an important emerging class of prognostic markers that can be used in the clinical evaluation of cancer patients. The markers review